Effect of magnesium sulfate pretreatment and significance of matrix metalloproteinase-1 and interleukin-6 levels in coronary reperfusion therapy for patients with acute myocardial infarction. [electronic resource]
Producer: 19990816Description: 573-82 p. digitalISSN:- 0003-3197
- Adult
- Aged
- Angina Pectoris -- etiology
- Angioplasty, Balloon, Coronary
- Arrhythmias, Cardiac -- etiology
- Calcium -- metabolism
- Calcium Channel Blockers -- administration & dosage
- Collagenases -- blood
- Complement System Proteins -- drug effects
- Electrocardiography -- drug effects
- Female
- Fibrinolytic Agents -- therapeutic use
- Humans
- Incidence
- Injections, Intravenous
- Interleukin-6 -- blood
- Magnesium -- blood
- Magnesium Sulfate -- administration & dosage
- Male
- Matrix Metalloproteinase 1
- Middle Aged
- Muscle, Smooth, Vascular -- drug effects
- Myocardial Infarction -- drug therapy
- Myocardial Reperfusion Injury -- etiology
- Myocardium -- metabolism
- Placebos
- Premedication
- Recurrence
- Thrombolytic Therapy
- Tissue Plasminogen Activator -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.